FDA OTC Labeling Guidance Allows Flexible Approach To Template Use
This article was originally published in The Tan Sheet
Executive Summary
OTC drug manufacturers that choose to employ FDA's "Drug Facts" labeling templates do not have to follow them verbatim, the agency says in a guidance published in the Oct. 18 Federal Register